Microeconomic Intervention to Reduce HIV Transmission in Economically Disadvantaged Transgender Women

Hiv Clinical Trial

Official title:

Microeconomic Intervention to Reduce HIV Transmission in Economically Disadvantaged Transgender Women

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT04275310
• Other study ID #: HM20011245
• Secondary ID: R34MH115775
• Status: Terminated
• Phase: N/A
• Start date: July 20, 2022
• Est. completion date: November 17, 2022

Study information

• Verified date: August 2023
• Source: Virginia Commonwealth University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this research study is to learn more about the economic situations, discrimination experiences, and risk behaviors of transgender women. The ultimate purpose of the study is to test an intervention to improve financial conditions and reduce HIV risk behaviors in transgender women.

Description:

The study includes a microeconomic intervention which will provide education on a variety of economic and behavioral topics. Participants will complete questionnaires on multiple occasions during the study.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 4
• Est. completion date: November 17, 2022
• Est. primary completion date: November 17, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• Transgender woman

• 18-45 years of age

At least one of the following economic vulnerability factors:

unemployment or underemployment [less than 20 hours/week], low income [less than the Medicaid poverty threshold], housing insecurity in the past year or food insecurity in the past year

• Behavioral vulnerability to HIV transmission (reported at least one episode of unprotected sex in prior 6 months or at least one other behavioral HIV transmission risk factor in the past 6 months: [transactional sex, multiple sexual partners, 1-time sexual partner, sex under the influence of drugs or alcohol, sex with partner of unknown HIV status).

Exclusion Criteria:

• obvious signs of intoxication or cognitive impairment

• cannot speak English.

Related Conditions & MeSH terms

• Hiv
• Transgenderism

Intervention

Behavioral:
• Microeconomic Intervention
The intervention will consist of six sessions on six different days. Sessions will be held at VCU or at one of VCU's community partners. Each session will last for around 2 ½ hours (around 15 hours total). There will be breaks and food will be provided. During the sessions the facilitators will provide education on a variety of topics, including economic services that are available to people living in Richmond, job skills (such as creating a resume and dealing with discrimination at work), personal finance education, gender transition ideas, and HIV prevention. The sessions will occur in a group of about 4-10 transgender women.

Locations

Country	Name	City	State
United States	Virginia Commonwealth University	Richmond	Virginia

Sponsors (2)

Lead Sponsor	Collaborator
Virginia Commonwealth University	National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Employment Status	Number of participants whose status with respect to employment improves after the intervention.	Baseline to up to 9 months
Primary	Change in Income	Number of participants whose income increases after the intervention.	Baseline to up to 9 months
Primary	Change in Housing Stability	Number of participants whose access to stable permanent housing improves after the intervention.	Baseline to up to 9 months
Primary	Change in Savings	Number of participants whose savings increase after the intervention.	Baseline to up to 9 months
Primary	Change in Self Reported HIV Risk Behavior	Number of participants whose self-reports of behaviors known to increase risk for HIV goes down after the intervention.	Baseline to up to 9 months
Primary	Change in Compliance With Recommended Biomedical Prevention or Treatment	Number of participants who demonstrate higher compliance with recommended biomedical prevention or treatment behaviors after the intervention.	Baseline to up to 9 months